Exposure and safety of higher doses of recombinant factor VIIa ≥250 µg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).
Haemophilia
; 17(4): 650-6, 2011 Jul.
Article
en En
| MEDLINE
| ID: mdl-21299750
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Factor VIIa
/
Hemofilia B
/
Hemofilia A
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
/
Infant
/
Middle aged
Idioma:
En
Año:
2011
Tipo del documento:
Article